Description
রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন*
Indications:
LUVIO is indicated for the treatment of hyperlipidemia and mixed dyslipidemia to reduce elevated LDL cholesterol, total cholesterol, and triglycerides.
Pharmacology:
This combination contains:
-
Atorvastatin 60 mg (statin class): inhibits HMG-CoA reductase to lower cholesterol synthesis.
-
Ezetimibe 30 mg: inhibits intestinal cholesterol absorption.
-
Fenofibrate 6 mg: activates PPAR-alpha, increasing lipid metabolism.
-
Niacin 2 mg: reduces VLDL synthesis and increases HDL.
-
Omega-3 fatty acids 15 mg: reduces triglyceride synthesis.
Together, these agents provide a multi-modal lipid-lowering effect.
Dosage & Administration:
Usually one tablet once daily, with or without food. Dosage may vary based on lipid levels and doctor’s advice.
Interaction:
May interact with other lipid-lowering agents, anticoagulants, and certain antibiotics. Avoid grapefruit juice with statins.
Contraindications:
Contraindicated in active liver disease, severe renal impairment, hypersensitivity to any component, and during pregnancy and lactation.
Side Effects:
Possible side effects include muscle pain, liver enzyme elevation, gastrointestinal disturbances, flushing, and increased blood sugar.
Pregnancy & Lactation:
Contraindicated during pregnancy and breastfeeding due to potential risks to the fetus and infant.
Precautions & Warnings:
Monitor liver function, muscle symptoms, and blood glucose regularly. Use caution in patients with a history of liver or kidney disease.
Therapeutic Class:
Lipid-lowering combination therapy
Storage Conditions:
Store in a cool, dry place below 30°C. Protect from moisture and light. Keep out of reach of children.
.jpg)
.jpg)
Change Language